184 related articles for article (PubMed ID: 19173677)
1. The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin.
Dolgova NV; Olson D; Lutsenko S; Dmitriev OY
Biochem J; 2009 Apr; 419(1):51-6, 3 p following 56. PubMed ID: 19173677
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B.
Dmitriev OY
Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266
[TBL] [Abstract][Full Text] [Related]
3. Sequence variation in the ATP-binding domain of the Wilson disease transporter, ATP7B, affects copper transport in a yeast model system.
Hsi G; Cullen LM; Macintyre G; Chen MM; Glerum DM; Cox DW
Hum Mutat; 2008 Apr; 29(4):491-501. PubMed ID: 18203200
[TBL] [Abstract][Full Text] [Related]
4. Copper binding to the N-terminal metal-binding sites or the CPC motif is not essential for copper-induced trafficking of the human Wilson protein (ATP7B).
Cater MA; La Fontaine S; Mercer JF
Biochem J; 2007 Jan; 401(1):143-53. PubMed ID: 16939419
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of chimeric proteins of the Wilson Cu(I)-ATPase (ATP7B) and ZntA, a Pb(II)/Zn(II)/Cd(II)-ATPase from Escherichia coli.
Hou ZJ; Narindrasorasak S; Bhushan B; Sarkar B; Mitra B
J Biol Chem; 2001 Nov; 276(44):40858-63. PubMed ID: 11527979
[TBL] [Abstract][Full Text] [Related]
6. Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.
Leonhardt K; Gebhardt R; Mössner J; Lutsenko S; Huster D
J Biol Chem; 2009 Mar; 284(12):7793-802. PubMed ID: 19141620
[TBL] [Abstract][Full Text] [Related]
7. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.
de Bie P; van de Sluis B; Burstein E; van de Berghe PV; Muller P; Berger R; Gitlin JD; Wijmenga C; Klomp LW
Gastroenterology; 2007 Oct; 133(4):1316-26. PubMed ID: 17919502
[TBL] [Abstract][Full Text] [Related]
8. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional insights of Wilson disease copper-transporting ATPase.
Fatemi N; Sarkar B
J Bioenerg Biomembr; 2002 Oct; 34(5):339-49. PubMed ID: 12539961
[TBL] [Abstract][Full Text] [Related]
10. Expression, purification, and metal binding characteristics of the putative copper binding domain from the Wilson disease copper transporting ATPase (ATP7B).
DiDonato M; Narindrasorasak S; Sarkar B
Adv Exp Med Biol; 1999; 448():165-73. PubMed ID: 10079824
[No Abstract] [Full Text] [Related]
11. Interactions between metal-binding domains modulate intracellular targeting of Cu(I)-ATPase ATP7B, as revealed by nanobody binding.
Huang Y; Nokhrin S; Hassanzadeh-Ghassabeh G; Yu CH; Yang H; Barry AN; Tonelli M; Markley JL; Muyldermans S; Dmitriev OY; Lutsenko S
J Biol Chem; 2014 Nov; 289(47):32682-93. PubMed ID: 25253690
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS; Zuzel V; Schmandt R; Leshane ES; Halder JB; Armaiz-Pena GN; Spannuth WA; Tanaka T; Shahzad MM; Lin YG; Nick AM; Danes CG; Lee JW; Jennings NB; Vivas-Mejia PE; Wolf JK; Coleman RL; Siddik ZH; Lopez-Berestein G; Lutsenko S; Sood AK
Clin Cancer Res; 2009 Jun; 15(11):3770-80. PubMed ID: 19470734
[TBL] [Abstract][Full Text] [Related]
13. Copper transfer to the N-terminal domain of the Wilson disease protein (ATP7B): X-ray absorption spectroscopy of reconstituted and chaperone-loaded metal binding domains and their interaction with exogenous ligands.
Ralle M; Lutsenko S; Blackburn NJ
J Inorg Biochem; 2004 May; 98(5):765-74. PubMed ID: 15134922
[TBL] [Abstract][Full Text] [Related]
14. Structures of the human Wilson disease copper transporter ATP7B.
Yang GM; Xu L; Wang RM; Tao X; Zheng ZW; Chang S; Ma D; Zhao C; Dong Y; Wu S; Guo J; Wu ZY
Cell Rep; 2023 May; 42(5):112417. PubMed ID: 37074913
[TBL] [Abstract][Full Text] [Related]
15. Copper transport and its defect in Wilson disease: characterization of the copper-binding domain of Wilson disease ATPase.
Sarkar B
J Inorg Biochem; 2000 Apr; 79(1-4):187-91. PubMed ID: 10830865
[TBL] [Abstract][Full Text] [Related]
16. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.
Tsivkovskii R; Efremov RG; Lutsenko S
J Biol Chem; 2003 Apr; 278(15):13302-8. PubMed ID: 12551905
[TBL] [Abstract][Full Text] [Related]
17. Molecular events initiating exit of a copper-transporting ATPase ATP7B from the trans-Golgi network.
Hasan NM; Gupta A; Polishchuk E; Yu CH; Polishchuk R; Dmitriev OY; Lutsenko S
J Biol Chem; 2012 Oct; 287(43):36041-50. PubMed ID: 22898812
[TBL] [Abstract][Full Text] [Related]
18. Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B.
Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Inesi G; Galliani A; Sinisi M; Losacco M; Natile G; Arnesano F
Angew Chem Int Ed Engl; 2014 Jan; 53(5):1297-301. PubMed ID: 24375922
[TBL] [Abstract][Full Text] [Related]
19. Purification and functional reconstitution of the human Wilson copper ATPase, ATP7B.
Portmann R; Solioz M
FEBS Lett; 2005 Jul; 579(17):3589-95. PubMed ID: 15963506
[TBL] [Abstract][Full Text] [Related]
20. Mallory bodies, like the mutant of ATP7B seen in Wilson disease, are aggresomes.
French S
Gastroenterology; 2001 Nov; 121(5):1264-6. PubMed ID: 11706834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
